{
 "as_of": "2026-11-06",
 "cmr": "ca-cm-kg/TSX/MDNA",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Medicenna Therapeutics Corp. (TSX: MDNA) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Medicenna Therapeutics Corp., listed on the TSX under ticker MDNA. Its ISIN is CA58490H1073 and its LEI is not on the record, as the ISIN is not in the GLEIF ISIN-to-LEI mapping file. Its security type is Corporate, its sector is Life Sciences, its segment is not on the record, and its jurisdiction is not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 13 filings in the twelve months to 2026-11-06, across 11 filing days. Of these, 11 are newswire releases and 2 are financial statements. The median gap between filing days is 23.0 days. The latest filing is dated 2026-11-04, is a newswire release, and is 2 days before the record date. The exchange median cadence gap is 16 days, the exchange median filings figure is 0.0, and the exchange median latency is 3.0 days. The sector median cadence gap is 17.5 days, the sector median filings figure is 7.0, and the sector median latency is 14 days.\n\n## Auditor\n\nThe auditor of record is not on the record, as none was found. The auditor's location is not on the record. The record carries no auditor changes.\n\n## Events and halts\n\nThe record carries no listing, delisting, name change, domicile change or segment move entries. The halt flag reads listed, not halted.\n\n## Orderability\n\nUnder rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, with the chapter as of 2026-11-04, paragraph (o) of the definition gives signal ACM-200 and is determinable. Paragraph (q) of the definition gives signal ACM-200 and is determinable.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage of this market is not sealed. The issuer has no sealed years on the record. The live record began on 2026-09-10. The years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.tsx.com/json/company-directory/search/tsx/^* (identity.exchange)\n- https://www.marketscreener.com/quote/stock/MEDICENNA-THERAPEUTICS-CO-34185015/news (identity.isin)\n- https://www.tsx.com/en/resource/571 (identity.sector)\n- https://mcp.ca-cm-kg.ai/events/TSX/MDNA (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ca-cm-kg.ai/record/TSX/MDNA (the record)\n",
 "market": "CA",
 "node": "ca-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-10",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "market": "CA",
    "reason": "none found",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "CA",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "CA",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "ca-cm-kg/TSX/MDNA",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [
    {
     "page": "https://ir.medicenna.com/stock-information/analyst-coverage",
     "result": "not readable by this rail (403)"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 2270,
     "median_cadence_gap_days": 16,
     "median_filings": 0,
     "median_latency_days": 3,
     "name": "TSX"
    },
    "sector": {
     "issuers": 200,
     "median_cadence_gap_days": 17.5,
     "median_filings": 7,
     "median_latency_days": 14,
     "name": "Life Sciences"
    }
   },
   "by_type": {
    "financial_statement": 2,
    "newswire_release": 11
   },
   "cadence_median_gap_days": 23,
   "filing_days": 11,
   "filings": 13,
   "latency_days": 2,
   "latest": [
    {
     "category": null,
     "date": "2026-11-04",
     "source": "https://www.globenewswire.com/news-release/2026/11/04/3395147/0/en/medicenna-completes-phase-1-2-ability-1-enrollment-and-announces-webinar-to-discuss-updated-mdna11-results-with-key-opinion-leaders.html",
     "title": "Medicenna Completes Phase 1/2 ABILITY-1 Enrollment and",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-26",
     "source": "https://www.globenewswire.com/news-release/2026/10/26/3388110/0/en/medicenna-reports-potent-cd122-blockade-and-extended-survival-with-mdna209-in-preclinical-models-of-autoimmune-disease.html",
     "title": "Medicenna Reports Potent CD122 Blockade and Extended",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-22",
     "source": "https://www.globenewswire.com/news-release/2026/10/22/3386188/0/en/medicenna-to-present-preclinical-data-on-its-cd122-superantagonist-mdna209-at-the-promises-of-treg-and-interleukin-2-therapies-conference.html",
     "title": "Medicenna to Present Preclinical Data on Its CD122",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-22",
     "source": "https://www.globenewswire.com/news-release/2026/10/22/3386188/0/en/index.html",
     "title": "Medicenna to Present Preclinical Data on Its CD122",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-05",
     "source": "https://www.globenewswire.com/news-release/2026/10/05/3374618/0/en/medicenna-announces-oral-presentation-of-topline-data-from-the-phase-1-2-ability-1-study-of-mdna11-at-sitc-2026.html",
     "title": "Medicenna Announces Oral Presentation of Topline Data from",
     "type": "newswire_release"
    }
   ],
   "latest_filing_date": "2026-11-04",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.ca-cm-kg.ai/events/TSX/MDNA",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsx/^*",
    "state": "sourced",
    "value": "TSX"
   },
   "isin": {
    "read_by": "Tavily search + regex extraction from page text",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.marketscreener.com/quote/stock/MEDICENNA-THERAPEUTICS-CO-34185015/news",
    "state": "confirmed",
    "value": "CA58490H1073"
   },
   "jurisdiction": {
    "market": "CA",
    "reason": "none found",
    "state": "not_on_record"
   },
   "lei": {
    "market": "CA",
    "reason": "ISIN not in the GLEIF ISIN-to-LEI mapping file",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsx/^*",
    "state": "sourced",
    "value": "Medicenna Therapeutics Corp."
   },
   "sector": {
    "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)",
    "state": "sourced",
    "value": "Life Sciences"
   },
   "security_type": {
    "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "CA",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsx/^*",
    "state": "sourced",
    "value": "MDNA"
   },
   "website": {
    "market": "CA",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": [],
   "listing": [],
   "name_change": [],
   "segment_move": []
  },
  "market": "CA",
  "node": "ca-cm-kg",
  "numbers_hash": "sha256:813df56906149c939f43a1a686ebffd56a1d6637b225c224167ee6b3b2c67882",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Paragraph (o) of the definition",
    "Paragraph (q) of the definition"
   ],
   "outcomes": {
    "Paragraph (o) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "Paragraph (q) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json",
    "door": "https://mcp.ca-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1",
   "section": "ca.aio.v11"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.ca-cm-kg.ai/record/TSX/MDNA",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:813df56906149c939f43a1a686ebffd56a1d6637b225c224167ee6b3b2c67882",
 "path": "/ca/TSX/MDNA",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Medicenna Therapeutics Corp., listed on the TSX under ticker MDNA. Its ISIN is CA58490H1073 and its LEI is not on the record, as the ISIN is not in the GLEIF ISIN-to-LEI mapping file. Its security type is Corporate, its sector is Life Sciences, its segment is not on the record, and its jurisdiction is not on the record. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 13 filings in the twelve months to 2026-11-06, across 11 filing days. Of these, 11 are newswire releases and 2 are financial statements. The median gap between filing days is 23.0 days. The latest filing is dated 2026-11-04, is a newswire release, and is 2 days before the record date. The exchange median cadence gap is 16 days, the exchange median filings figure is 0.0, and the exchange median latency is 3.0 days. The sector median cadence gap is 17.5 days, the sector median filings figure is 7.0, and the sector median latency is 14 days.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is not on the record, as none was found. The auditor's location is not on the record. The record carries no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record carries no listing, delisting, name change, domicile change or segment move entries. The halt flag reads listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "Under rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, with the chapter as of 2026-11-04, paragraph (o) of the definition gives signal ACM-200 and is determinable. Paragraph (q) of the definition gives signal ACM-200 and is determinable.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations page.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage of this market is not sealed. The issuer has no sealed years on the record. The live record began on 2026-09-10. The years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.tsx.com/json/company-directory/search/tsx/^*"
  },
  {
   "for": "identity.isin",
   "source": "https://www.marketscreener.com/quote/stock/MEDICENNA-THERAPEUTICS-CO-34185015/news"
  },
  {
   "for": "identity.sector",
   "source": "https://www.tsx.com/en/resource/571"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.ca-cm-kg.ai/events/TSX/MDNA"
  },
  {
   "for": "the halt flag",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.ca-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.ca-cm-kg.ai/record/TSX/MDNA"
  }
 ],
 "title": "Medicenna Therapeutics Corp. (MDNA) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}